Medications for Chronic Hepatitis B

6 results

  • Adefovir dipivoxil (adefovir dipivoxil)

    (ADEFOVIR DIPIVOXIL)
    Sigmapharm Laboratories, LLC
    Usage: Adefovir Dipivoxil Tablets are indicated for treating chronic hepatitis B in patients aged 12 and older with active viral replication and elevated serum aminotransferases or histologically active disease. This includes cases with lamivudine-resistant hepatitis B virus in both compensated and decompensated liver function.

  • Hepsera (adefovir dipivoxil)

    (Adefovir Dipivoxil)
    Excella GmbH
    Usage: HEPSERA is indicated for treating chronic hepatitis B in patients aged 12 years and older with active viral replication, elevated serum aminotransferases, or histologically active disease. It is approved based on various response types in both adults and adolescents with compensated liver function.

  • Lamivudine (lamivudine)

    (lamivudine)
    Prasco Laboratories
    Usage: Lamivudine tablets (HBV) are indicated for treating chronic hepatitis B virus infection characterized by viral replication and active liver inflammation. Treatment should be considered only when alternative antiviral options with a lower resistance risk are unavailable. Not evaluated in HIV, HCV, or hepatitis delta co-infection.

  • Tenofovir disoproxil fumarate (tenofovir disoproxil fumarate)

    (Tenofovir Disoproxil Fumarate)
    NorthStar RxLLC
    Usage: Tenofovir disoproxil fumarate tablets are indicated for the treatment of HIV-1 infection in adults and pediatric patients 2 years and older, and for chronic hepatitis B in adults and patients 12 years and older, in combination with other antiviral agents. Cautions on specific drug combinations are noted.

  • Tenofovir disoproxil fumarate (tenofovir disoproxil fumarate)

    (tenofovir disoproxil fumarate)
    Macleods Pharmaceuticals Limited
    Usage: Tenofovir disoproxil fumarate tablets are indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, and for chronic hepatitis B virus (HBV) in adults and pediatric patients aged 2 years and older weighing at least 10 kg.

  • Viread access (tenofovir disoproxil fumarate)

    (TENOFOVIR DISOPROXIL FUMARATE)
    Gilead Sciences Inc
    Usage: VIREAD™ is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents and for chronic hepatitis B virus (HBV) infection in adults and pediatric patients aged 12 and older.